| | | Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
Abstract
Background
Many pregnant persons in the United States are receiving messenger RNA (mRNA) coronavirus disease 2019 (Covid-19) vaccines, but data are limited on their safety in pregnancy.
Methods
From December 14, 2020, to February 28, 2021, we used data from the “v-safe after vaccination health checker” surveillance system, the v-safe pregnancy registry, and the Vaccine Adverse Event Reporting System (VAERS) to characterize the initial safety of mRNA Covid-19 vaccines in pregnant persons.
Results
A total of 35,691 v-safe participants 16 to 54 years of age identified as pregnant. Injection-site pain was reported more frequently among pregnant persons than among nonpregnant women, whereas headache, myalgia, chills, and fever were reported less frequently. Among 3958 participants enrolled in the v-safe pregnancy registry, 827 had a completed pregnancy, of which 115 (13.9%) were pregnancy losses and 712 (86.1%) were live births
------
That still sounds bad but consider -
Among women who know they are pregnant, up to 25 percent of those pregnancies will end in a miscarriage, according to the National Library of Medicine.
That percentage is at the top of the institution’s estimated number of knowingly pregnant women who will have a miscarriage (10 to 25 percent)
washingtonpost.com
So 10 to 25% have miscarriages normally. And 13.9% after a study of the issue among vaccinated women. |
|
